P04.81 Newborn affected by maternal use of cannabis

Name of the Condition

• Newborn affected by maternal use of cannabis
• ICD Code: P04.81

Summary

This condition describes health effects in a newborn resulting from maternal use of cannabis during pregnancy or breastfeeding. Cannabis compounds can cross the placenta and may be present in breast milk, potentially impacting the newborn's health and development.

Causes

Maternal use of cannabis during pregnancy or lactation can lead to fetal or neonatal exposure. The active compounds in cannabis, such as THC, may cross the placenta and accumulate in breast milk, affecting the newborn. The timing, frequency, and dosage of maternal use influence the newborn's condition.

Risk Factors

• Maternal cannabis use during pregnancy or breastfeeding
• Lack of prenatal screening for substance use
• Concurrent use of other substances (e.g., alcohol, tobacco)
• Inadequate prenatal care or substance use counseling

Symptoms

Symptoms may include poor feeding, lethargy, jitteriness, or withdrawal signs. Some newborns may exhibit respiratory distress, growth restriction, or neurobehavioral abnormalities. Long-term effects on neurodevelopment are possible but may not be immediately apparent.

Diagnosis

Diagnosis involves a thorough maternal history review, including substance use details, and newborn clinical assessment. Laboratory testing for cannabis metabolites in meconium or urine may be considered, though results depend on timing and exposure patterns.

Treatment Options

Treatment focuses on managing symptoms, such as supportive care for withdrawal or respiratory support if needed. Feeding support and monitoring for growth or developmental concerns are also important. Maternal counseling on substance use cessation is recommended.

Prognosis and Follow-Up

Prognosis varies based on exposure severity and duration. Close follow-up is needed to monitor growth, neurodevelopment, and potential long-term effects. Early intervention services may be beneficial for infants with concerning findings.

Complications

Potential complications include respiratory issues, feeding difficulties, growth restriction, or neurodevelopmental delays. Severe cases may require hospitalization or specialized care.

Lifestyle & Prevention

Prevention involves maternal education on the risks of cannabis use during pregnancy and lactation. Avoiding substance use and seeking prenatal care can reduce exposure risks. Support for maternal cessation programs is encouraged.

When to Seek Professional Help

Seek medical attention if the newborn shows signs of distress, poor feeding, lethargy, or withdrawal symptoms. Maternal substance use should be disclosed to healthcare providers for appropriate evaluation and management.

Tips for Medical Coders

Document maternal cannabis use details, including timing (pregnancy vs. lactation) and exposure context. Ensure clear correlation between maternal history and newborn findings. Code P04.81 is specific to cannabis; do not use for other substances.